TransMedics Group (TMDX) Financial Statements & Analysis

TransMedics Group (TMDX) Income Statement

TransMedics Group reported revenue of $605.49M in fiscal 2025 (fiscal year ended Dec 31, 2025), up 37.1% from $441.54M a year earlier. Net income was $190.29M, up 436.6% year over year, a net margin of 31.4%. Gross margin was 59.9% and operating margin 17.9%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $189.95M, up 20.7% from the same quarter a year earlier.

TransMedics Group Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

TransMedics Group, Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Revenue & Gross Profit
Revenue	605.49	441.54	241.62	93.46	30.26	25.64	23.60	13.02	7.69
Cost of Revenue	242.69	179.46	87.53	28.19	9.10	9.00	9.74	7.28	5.55
Gross Profit	362.81	262.08	154.09	65.27	21.16	16.64	13.86	5.73	2.14
Operating Expenses
Research & Development	69.06	55.97	36.06	26.81	22.30	18.83	19.87	13.66	14.96
Selling, General & Administrative	185.17	168.62	119.55	69.90	38.28	24.19	23.60	12.32	7.61
Operating Expenses	254.22	224.59	146.77	96.71	60.59	43.02	43.47	25.97	22.56
Operating Income	108.58	37.50	-28.73	-31.44	-39.43	-26.38	-29.60	-20.24	-20.43
Other Income/Expense
Interest Income	0.00	12.69	12.85	0.90	-0.88	1.65	0.79	0.00	0.55
Interest Expense	13.78	-14.41	-10.79	3.73	-3.87	3.99	4.35	2.42	1.07
Other Income/Expense	12.72	-1.72	2.06	-4.73	-4.75	-2.33	-3.90	-3.48	-0.37
Income
Income Before Tax	107.52	35.78	-26.67	-36.17	-44.18	-28.72	-33.51	-23.72	-20.79
Income Tax Expense	-82.77	0.32	-1.64	0.07	0.04	0.03	0.04	0.04	0.03
Net Income	190.29	35.46	-25.03	-36.23	-44.22	-28.75	-33.55	-23.76	-20.82
Net Income - Continuous Operations	190.29	35.46	-25.03	-36.23	-44.22	-28.75	-33.55	-23.76	-20.82
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-	-
EBITDA	148.49	57.25	6.66	-28.96	-37.61	-23.15	-27.93	-20.23	-19.09
EBIT	121.30	37.50	-1.52	-31.44	-39.43	-26.38	-	-	-
Depreciation & Amortization	27.19	19.76	8.18	3.48	1.82	1.58	1.22	0.77	0.63
Earnings Per Share
Basic EPS	6.00	1.00	-1.00	-1.00	-2.00	-1.00	-2.00	-1.00	-1.00
Diluted EPS	5.00	1.00	-1.00	-1.00	-2.00	-1.00	-2.00	-1.00	-1.00
Basic Shares Outstanding	33.99	33.23	32.52	29.56	27.62	24.70	14.20	19.25	14.48
Diluted Shares Outstanding	40.54	35.22	32.52	29.56	27.62	24.70	14.20	19.25	14.48

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About TransMedics Group Financial Statements

What was TransMedics Group's revenue in fiscal 2025?

TransMedics Group reported revenue of $605.49M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 37.1% from $441.54M a year earlier.

Is TransMedics Group profitable?

Yes. TransMedics Group earned net income of $190.29M in fiscal 2025, a net margin of 31.4%. In fiscal 2024 it earned $35.46M.

What is TransMedics Group's operating margin?

TransMedics Group's operating income was $108.58M on revenue of $605.49M in fiscal 2025, an operating margin of 17.9%, compared with 8.5% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition